8-K: iQSTEL Inc. Grants $100,000 Common Stock Purchase Option to ADI Funding LLC

iQSTEL Inc. has granted a common stock purchase option to ADI Funding LLC for $100,000, allowing them to acquire up to 10 million shares of common stock.

Summary

• iQSTEL Inc. issued a Common Stock Purchase Option to ADI Funding LLC on February 12, 2024, for $100,000.
• The option allows ADI Funding to purchase up to 10 million shares of iQSTEL common stock.
• The option expires on December 31, 2024.
• The exercise price is based on the volume-weighted average price (VWAP) of the stock over the 10 trading days prior to exercise.
• If the VWAP is below $2.00, the exercise price is 70% of the VWAP.
• If the VWAP is $2.00 or above, the exercise price is 75% of the VWAP.
• ADI Funding is obligated to purchase at least 2 million shares by the later of March 31, 2024, or the date a resale registration statement is effective.
• Subsequent exercises must be for at least 1 million shares every 30 days.
• The exercise price cannot be less than $0.11 per share.
• ADI Funding's ownership is limited to 4.99% of outstanding shares, which can be increased to 9.99% with notice.
• The option includes rights to company distributions and consideration in fundamental transactions, subject to ownership limits.

Sentiment

Score: 6

Explanation: The document outlines a standard financing agreement, which is neither overwhelmingly positive nor negative. The potential for dilution is a concern, but the capital infusion is a positive.

Positives

• iQSTEL receives $100,000 upfront for the option.
• The agreement guarantees a minimum purchase of 2 million shares by ADI Funding.
• The structure of the option provides a potential source of capital for iQSTEL through future exercises.
• The exercise price is tied to the market price of the stock, which could be beneficial if the stock price increases.

Negatives

• The exercise price is discounted from the market price, potentially diluting existing shareholders.
• The minimum exercise price of $0.11 could be significantly below the current market price.
• The obligation to exercise is subject to a minimum price of $0.11, which could be a negative if the share price falls below this level.
• The potential for increased ownership by ADI Funding could lead to a shift in control.

Risks

• The exercise of the option could dilute existing shareholders.
• The minimum exercise price of $0.11 could result in a lower price than the market price.
• The agreement could lead to increased ownership by ADI Funding, potentially impacting control.
• The company is obligated to deliver shares within a specific timeframe, and failure to do so could result in penalties.

Future Outlook

The company anticipates potential capital infusion through the exercise of the option by ADI Funding, subject to market conditions and the terms of the agreement.

Management Comments

• The company has not provided any specific management comments in this document.

Industry Context

This type of financing agreement is common in the small-cap market, providing companies with access to capital while offering investors potential upside through equity participation.

Comparison to Industry Standards

• Similar agreements are often seen with small-cap companies seeking funding, with the terms varying based on the company's valuation and market conditions.
• The use of VWAP-based pricing is a common mechanism to determine the exercise price in such agreements.
• The minimum exercise price of $0.11 is relatively low, which could be a point of concern for existing shareholders.
• The beneficial ownership limitations are standard to prevent a single entity from gaining too much control.

Stakeholder Impact

• Shareholders may experience dilution if the option is exercised.
• The company may benefit from the capital infusion.
• ADI Funding will have the opportunity to acquire a significant stake in the company.

Next Steps

• ADI Funding will need to decide whether to exercise the option for the initial 2 million shares by the deadline.
• The company will need to ensure the registration statement is effective to allow for the resale of shares by ADI Funding.
• The company will need to monitor the stock price to determine the exercise price for future exercises.

Key Dates

Keywords

common stock purchase option, ADI Funding LLC, equity financing, share dilution, VWAP, exercise price, capital raise